INDIANAPOLIS (AP) — European regulators approved the use of an imaging agent from Eli Lilly, which can help doctors diagnose Alzheimer’s disease.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.